These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 35866877
21. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer. Zhang ZH, Li MY, Wang Z, Zuo HX, Wang JY, Xing Y, Jin C, Xu G, Piao L, Piao H, Ma J, Jin X. Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989 [Abstract] [Full Text] [Related]
22. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma. Zhang G, He J, Ye X, Zhu J, Hu X, Shen M, Ma Y, Mao Z, Song H, Chen F. Cell Death Dis; 2019 Mar 15; 10(4):255. PubMed ID: 30874538 [Abstract] [Full Text] [Related]
23. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways. Yang L, Hu Y, Zhou G, Chen Q, Song Z. Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32677672 [Abstract] [Full Text] [Related]
24. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling. Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L. J Biochem Mol Toxicol; 2021 Oct 31; 35(10):e22871. PubMed ID: 34338398 [Abstract] [Full Text] [Related]
25. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Kim MN, Lee SM, Kim JS, Hwang SG. Cancer Chemother Pharmacol; 2019 Oct 31; 84(4):809-817. PubMed ID: 31385002 [Abstract] [Full Text] [Related]
26. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways. Cui SX, Shi WN, Song ZY, Wang SQ, Yu XF, Gao ZH, Qu XJ. Oncotarget; 2016 Jun 14; 7(24):36767-36782. PubMed ID: 27167344 [Abstract] [Full Text] [Related]
27. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Grabinski N, Ewald F, Hofmann BT, Staufer K, Schumacher U, Nashan B, Jücker M. Mol Cancer; 2012 Nov 20; 11():85. PubMed ID: 23167739 [Abstract] [Full Text] [Related]
28. PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways. Gedaly R, Angulo P, Hundley J, Daily MF, Chen C, Koch A, Evers BM. Anticancer Res; 2010 Dec 20; 30(12):4951-8. PubMed ID: 21187475 [Abstract] [Full Text] [Related]
29. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC. Carcinogenesis; 2013 Jun 20; 34(6):1331-42. PubMed ID: 23393227 [Abstract] [Full Text] [Related]
30. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY. Wang WD, Liu Y, Su Y, Xiong XZ, Shang D, Xu JJ, Liu HJ. Afr J Tradit Complement Altern Med; 2017 Jun 20; 14(2):75-82. PubMed ID: 28573224 [Abstract] [Full Text] [Related]
31. Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways. Qian YY, Li WY, Yan Y, Zhao XY, Yang T, Fang CC, Hou JJ, Liu YQ. Chin J Integr Med; 2019 Nov 20; 25(11):845-852. PubMed ID: 31127506 [Abstract] [Full Text] [Related]
32. Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway. Jin J, Guo Y, Liu Y, Wang Z, Yang X, Sun S. Oncol Rep; 2019 Sep 20; 42(3):1183-1193. PubMed ID: 31233204 [Abstract] [Full Text] [Related]
34. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Yang J, Pi C, Wang G. Biomed Pharmacother; 2018 Jul 20; 103():699-707. PubMed ID: 29680738 [Abstract] [Full Text] [Related]
35. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis. Johnson MD, O'Connell MJ, Walter K. BMC Complement Altern Med; 2013 Nov 04; 13():303. PubMed ID: 24188277 [Abstract] [Full Text] [Related]
36. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway. Hong SW, Jung KH, Lee HS, Choi MJ, Son MK, Zheng HM, Hong SS. Cancer Sci; 2012 Nov 04; 103(11):1929-37. PubMed ID: 22909393 [Abstract] [Full Text] [Related]
37. Apoptotic effect of compound K in hepatocellular carcinoma cells via inhibition of glycolysis and Akt/mTOR/c-Myc signaling. Shin N, Lee HJ, Sim DY, Im E, Park JE, Park WY, Cho AR, Shim BS, Kim SH. Phytother Res; 2021 Jul 04; 35(7):3812-3820. PubMed ID: 33856720 [Abstract] [Full Text] [Related]
38. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway. Wang SS, Chen YH, Chen N, Wang LJ, Chen DX, Weng HL, Dooley S, Ding HG. Cell Death Dis; 2017 Mar 23; 8(3):e2688. PubMed ID: 28333142 [Abstract] [Full Text] [Related]
40. Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway. Sun R, Zhai R, Ma C, Miao W. Cancer Med; 2020 Feb 23; 9(3):1141-1151. PubMed ID: 31830378 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]